Publications and Results

Trindade, F.; Sopić, M.; Davies, M.J.; Tsatsanis, C.; Pinet, F.; Ferreira, H.B.; Munjas, J.; Mayilyan, K.; Formosa, M.M.; Attard, R.; Farrugia, R.; Vitorino, R.; Khatib, S.; Bezzina Wettinger, S.; Novella, S.; Kosek, V.; Sohrabi, Y.; Magni, P.; Devaux, Y.; de Gonzalo-Calvo, D.; Mardal, M. (2026). Relevance of preanalytical factors in multiomics: Toward a standardized blood processing protocol. Trends in Analytical Chemistry, 196, Article 118676.
Bezzina Wettinger, S.; Karaduzovic-Hadziabdic, K.; Attard, R.; Farrugia, R.; Wolford, B.N.; Chierici, M.; Jurman, G.; Alexiou, P.; Peñalvo, J.L.; Costa, R.S.; Basílio, J.; Sabovčik, F.; Vitorino, R.; Schmid, J.A.; Shigdel, R.; Vilne, B.; Hatzigeorgiou, A.G.; Sopić, M.; Devaux, Y.; Magni, P.; Tellez-Plaza, M.; Kreil, D.P.; Gruca, A. (2025). Bottlenecks in advancing and applying multiomic data integration – common data resources as rate-limiting drivers – the high-impact use case of atherosclerotic cardiovascular disease. Briefings in Bioinformatics, 26(5), bbaf526.
Mitić, T.; Georgescu, A.; Alexandru-Moise, N.; Davies, M.J.; Vindis, C.; Novella, S.; Gerdts, E.; Kararigas, G.; Bezzina Wettinger, S.; Formosa, M.M.; Kwak, B.R.; Molica, F.; Amigó, N.; Caporali, A.; de la Cuesta, F.; Hall, I.F.; Chroni, A.; Martelli, F.; Schmid, J.A.; Magni, P.; Kardassis, D. (2025). Current status and challenges of multi-omics research using animal models of atherosclerosis. Journal of Molecular and Cellular Cardiology Plus, 13, 100476.
Nordestgaard LT, Wolford BN, de Gonzalo-Calvo D, Sopić M, Devaux Y, Matic L, Bezzina Wettinger S, Schmid JA, Amigó N, Masana L, Catapano AL, Kardassis D, Magni P; EU-AtheroNET COST Action CA21153. Multiomics in atherosclerotic cardiovascular disease. Atherosclerosis, Sep;408:120414, 2025. Epub 2025 Jun 26. PMID: 40663987.
Stopa, V.; Dafou, D.; Karagianni, K.; Yaël Nossent, A.; Farrugia, R.; Devaux, Y.; Sopić, M. (2025). Epitranscriptomics in atherosclerosis: Unraveling RNA modifications, editing and splicing and their implications in vascular disease. Vascular Pharmacology, 159, 107496.
Alexiou, P.; Gruca, A.; Basílio, J.; Karaduzovic-Hadziabdic, K.; Kreil, D.P.; Bezzina Wettinger, S. (2026). In Transcriptomics in Atherosclerosis (Eds. Y. Devaux & M. Sopić), Integrating genomics, transcriptomics, proteomics, metabolomics, and other omics, Chapter 12, pp. 223–242. Elsevier.
Sopic, Miron; Vilne, Baiba; Gerdts, Eva; Trindade, Fábio; Uchida, Shizuka; Khatib, Soliman; Bezzina Wettinger, Stephanie; Devaux, Yvan; Magni, Paolo, on behalf of EU-AtheroNET COST Action CA21153. (2023). Multiomics tools for improved atherosclerotic cardiovascular disease management. Trends in Molecular Medicine, 29(12), 983-995.

https://www.um.edu.mt/projects/targetmi/publicationsandresults/